Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda S Wyatt

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Virology|August 3, 2010
The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 proteinKaori Shinoda, Linda S Wyatt, Bernard Moss
Current Protocols in Molecular Biology|January 7, 2017
Generation of Recombinant Vaccinia VirusesLinda S Wyatt, Patricia L Earl, Bernard Moss
Current Protocols in Protein Science|August 2, 2017
Generation of Recombinant Vaccinia VirusesLinda S Wyatt, Patricia L Earl, Bernard Moss
Current Protocols in Microbiology|November 4, 2015
Generation of Recombinant Vaccinia VirusesLinda S Wyatt, Patricia L Earl, Bernard Moss
Virology Journal|March 5, 2009
Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunizationKaori Shinoda, Linda S Wyatt, Kari R Irvine, et al.
Vaccine|August 10, 2013
Attenuation and immunogenicity of host-range extended modified vaccinia virus Ankara recombinantsSharon Melamed, Linda S Wyatt, Robin J Kastenmayer, et al.
Current Protocols in Protein Science|August 2, 2017
Preparation of Cell Cultures and Vaccinia Virus StocksCatherine A Cotter, Patricia L Earl, Linda S Wyatt, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2004
Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challengeLinda S Wyatt, Patricia L Earl, Leigh Anne Eller, et al.
Current Protocols in Molecular Biology|January 7, 2017
Preparation of Cell Cultures and Vaccinia Virus StocksCatherine A Cotter, Patricia L Earl, Linda S Wyatt, et al.
Current Protocols in Microbiology|November 4, 2015
Preparation of Cell Cultures and Vaccinia Virus StocksCatherine A Cotter, Patricia L Earl, Linda S Wyatt, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Virology|August 3, 2010
The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 proteinKaori Shinoda, Linda S Wyatt, Bernard Moss
Current Protocols in Molecular Biology|January 7, 2017
Generation of Recombinant Vaccinia VirusesLinda S Wyatt, Patricia L Earl, Bernard Moss
Current Protocols in Protein Science|August 2, 2017
Generation of Recombinant Vaccinia VirusesLinda S Wyatt, Patricia L Earl, Bernard Moss
Current Protocols in Microbiology|November 4, 2015
Generation of Recombinant Vaccinia VirusesLinda S Wyatt, Patricia L Earl, Bernard Moss
Virology Journal|March 5, 2009
Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunizationKaori Shinoda, Linda S Wyatt, Kari R Irvine, et al.
Vaccine|August 10, 2013
Attenuation and immunogenicity of host-range extended modified vaccinia virus Ankara recombinantsSharon Melamed, Linda S Wyatt, Robin J Kastenmayer, et al.
Current Protocols in Protein Science|August 2, 2017
Preparation of Cell Cultures and Vaccinia Virus StocksCatherine A Cotter, Patricia L Earl, Linda S Wyatt, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2004
Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challengeLinda S Wyatt, Patricia L Earl, Leigh Anne Eller, et al.
Current Protocols in Molecular Biology|January 7, 2017
Preparation of Cell Cultures and Vaccinia Virus StocksCatherine A Cotter, Patricia L Earl, Linda S Wyatt, et al.
Current Protocols in Microbiology|November 4, 2015
Preparation of Cell Cultures and Vaccinia Virus StocksCatherine A Cotter, Patricia L Earl, Linda S Wyatt, et al.
Pageof 6